David E. Wynne

Biography

Mr. Wynne is President and CEO of Ozonator International Pte Ltd (OIPL). David has over thirty years experience in international business development, venture capital, finance and operations, in particular with start ups and small cap technology firms. He was previously Executive Director and COO for Zecotek Photonics Ltd, a leading Canadian photonics company. He recently resigned from the Board and active management to devote his attention to OIPL, but remains advisor to the Company. In 2001 he was a co-founder of MerLion Pharmaceuticals Pte Ltd, now a leading Singapore-based drug discovery company, where he held positions of COO and CBO during its formation. He has been an active partner and remains advisor to Upstream Ventures, a Singapore-based early stage venture capital firm, and previously as Senior Vice President and a Board representative of Transpac Capital, one of Asia's oldest and largest venture capital companies. He was also co-founder and investor in the Canadian software company Greenbook, which produced one of the first hypertext authoring tools for the Internet. Before entering the private sector he served as a senior diplomat for Canada in Korea, Japan and Singapore, and in APEC, as Canada's representative to the APEC Budget and Administration Committee and as the Canadian Deputy Chair of the APEC Economic Committee. During his APEC tenure, he was responsible for the organization of the Canadian Prime Minister's participation in three Leader's Meetings (Seattle, Bogor and Osaka) reporting directly to the Canadian Prime Minister's Office. Mr. Wynne earned a Bachelor of Arts degree from Concordia University, Montreal, Canada and a Master of Arts in Public Administration & Economics from Carleton University, Ottawa, Canada. He has served on the Executive Committee of the Singapore Venture Capital Association, the Executive Council of the Singapore Biotech Association and the Executive Council of the Canadian Chamber of Commerce in Singapore. 

Research Interest

Mr. Wynne is President and CEO of Ozonator International Pte Ltd (OIPL). David has over thirty years experience in international business development, venture capital, finance and operations, in particular with start ups and small cap technology firms. He was previously Executive Director and COO for Zecotek Photonics Ltd, a leading Canadian photonics company. He recently resigned from the Board and active management to devote his attention to OIPL, but remains advisor to the Company. In 2001 he was a co-founder of MerLion Pharmaceuticals Pte Ltd, now a leading Singapore-based drug discovery company, where he held positions of COO and CBO during its formation. He has been an active partner and remains advisor to Upstream Ventures, a Singapore-based early stage venture capital firm, and previously as Senior Vice President and a Board representative of Transpac Capital, one of Asia's oldest and largest venture capital companies. He was also co-founder and investor in the Canadian software company Greenbook, which produced one of the first hypertext authoring tools for the Internet. Before entering the private sector he served as a senior diplomat for Canada in Korea, Japan and Singapore, and in APEC, as Canada's representative to the APEC Budget and Administration Committee and as the Canadian Deputy Chair of the APEC Economic Committee. During his APEC tenure, he was responsible for the organization of the Canadian Prime Minister's participation in three Leader's Meetings (Seattle, Bogor and Osaka) reporting directly to the Canadian Prime Minister's Office. Mr. Wynne earned a Bachelor of Arts degree from Concordia University, Montreal, Canada and a Master of Arts in Public Administration & Economics from Carleton University, Ottawa, Canada. He has served on the Executive Committee of the Singapore Venture Capital Association, the Executive Council of the Singapore Biotech Association and the Executive Council of the Canadian Chamber of Commerce in Singapore.